Neutrophil Elastase Facilitates Tumor Cell Intravasation and Early Metastatic Events
Overview
Authors
Affiliations
Functional roles of neutrophil elastase (NE) have not been examined in distinct steps of the metastatic cascade. NE, delivered to primary tumors as a purified enzyme or within intact neutrophils or neutrophil granule content, enhanced human tumor cell intravasation and subsequent dissemination via NE-mediated formation of dilated intratumoral vasculature. These effects depended on picomole range of NE activity, sensitive to its natural inhibitor, α1PI. In -negative mice, the lack of NE decreased lung retention of human tumor cells in experimental metastasis. Furthermore, NE was essential for spontaneous metastasis of murine carcinoma cells in a syngeneic orthotopic model of oral cancer. NE also induced tumor cell survival and migration via Src/PI3K-dependent activation of Akt signaling, vital for tumor cell dissemination . Together, our findings implicate NE, a potent host enzyme specific for first-responding innate immune cells, as directly involved in early metastatic events and a potential target for therapeutic intervention.
The heterogeneity of neutrophils in cancer and its implication for therapeutic targeting.
Eruslanov E, Nefedova Y, Gabrilovich D Nat Immunol. 2025; 26(1):17-28.
PMID: 39747431 DOI: 10.1038/s41590-024-02029-y.
Neutrophil extracellular traps in tumor progression of gynecologic cancers.
Chen H, Zhou Y, Tang Y, Lan J, Lin C, Chen Q Front Immunol. 2024; 15:1421889.
PMID: 39555072 PMC: 11563837. DOI: 10.3389/fimmu.2024.1421889.
Filliatre M, Seren S, Embo-Ibouanga A, Joly J, Bouchaud V, Kelkoul I ACS Omega. 2024; 9(37):39004-39012.
PMID: 39310132 PMC: 11411533. DOI: 10.1021/acsomega.4c05592.
Innate immune cells in tumor microenvironment: A new frontier in cancer immunotherapy.
Li C, Yu X, Han X, Lian C, Wang Z, Shao S iScience. 2024; 27(9):110750.
PMID: 39280627 PMC: 11399700. DOI: 10.1016/j.isci.2024.110750.
Targeting NETosis: nature's alarm system in cancer progression.
Liang Y, Wu G, Tan J, Xiao X, Yang L, Saw P Cancer Drug Resist. 2024; 7:28.
PMID: 39143953 PMC: 11322967. DOI: 10.20517/cdr.2024.24.